Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
About the company
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.
Stock price
Gross Margin (in %)
Operating Margin (in %)
Net Margin (in %)
Dividend Yield (in %)
Revenues - Income - Cash Flows (in USD Million)
Margins (in %)
Return on capital (in %)
Ratios (in %)
Industry margins
Industry workforces
Industry revenues and market cap
Industry ratios
90-days Stock Price Forecast (in %)
Industry peers
| Name | Ticker | Market capitalization (in USD Million) | Revenues (in USD Million) | Price/Book | Price/Earning | Net margin (in %) |
|---|---|---|---|---|---|---|
| Johnson & Johnson | JNJ | 377376.69 | 82729.00 | 6.06 | 21.99 | 20.75 |
| Merck & Co., Inc. | MRK | 204202.28 | 48081.00 | 7.67 | 20.15 | 21.10 |
| Pfizer Inc. | PFE | 194670.90 | 50660.00 | 2.95 | 12.32 | 31.17 |
| Eli Lilly & Co. | LLY | 153205.02 | 23087.00 | 51.99 | 27.00 | 23.97 |
| AbbVie, Inc. | ABBV | 146737.92 | 34057.00 | -23.49 | 17.50 | 24.65 |
| Bristol Myers Squibb Co. | BMY | 110414.38 | 31006.00 | 2.68 | 93.87 | 3.08 |
| Repligen Corp. | RGEN | 6456.09 | 286.00 | 6.19 | 281.31 | 8.11 |
| Reata Pharmaceuticals, Inc. | RETA | 4978.60 | 20.00 | 23.58 | -16.01 | -150.30 |
| Nektar Therapeutics | NKTR | 4220.48 | 137.00 | 3.29 | -9.19 | -335.62 |
| Biohaven Pharmaceutical Holding Co. Ltd. | BHVN | 3702.40 | 1.00 | 34.23 | -5.66 | None |
| Allakos, Inc. | ALLK | 3122.21 | None | 6.78 | -33.38 | None |
| Karuna Therapeutics, Inc. | KRTX | 2853.24 | None | 7.45 | -70.35 | None |
| ADC Therapeutics SA | ADCT | 2642.22 | 2.00 | 31.17 | -22.65 | None |
| OPKO Health, Inc. | OPK | 2289.84 | 891.00 | 1.63 | -7.83 | -32.92 |
| Turning Point Therapeutics, Inc. | TPTX | 2259.00 | None | 6.80 | -18.90 | None |
| IGM Biosciences, Inc. | IGMS | 2244.09 | None | 9.89 | -41.37 | None |
| Apellis Pharmaceuticals, Inc. | APLS | 2175.36 | None | 9.61 | -5.22 | None |
| Ra Pharmaceuticals, Inc. | RARX | 2111.78 | 3.00 | 8.68 | -20.78 | -585.71 |
| Springworks Therapeutics, Inc. | SWTX | 1743.65 | None | 5.66 | -27.97 | None |
| Principia Biopharma, Inc. | PRNB | 1568.00 | 30.00 | 5.58 | -22.31 | -242.01 |
| Y-mAbs Therapeutics, Inc. | YMAB | 1551.78 | None | 9.51 | -16.84 | None |
| Zymeworks, Inc. | ZYME | 1511.16 | 26.00 | 3.14 | -8.91 | -629.37 |
| Akcea Therapeutics, Inc. | AKCA | 1370.61 | 341.00 | 2.81 | -48.72 | -8.59 |
| Kiniksa Pharmaceuticals Ltd. | KNSA | 1305.15 | None | 6.76 | -10.79 | None |
| Tricida, Inc. | TCDA | 1301.44 | None | 6.69 | -6.16 | None |
| Arcutis Biotherapeutics, Inc. | ARQT | 1184.37 | None | 5.05 | -18.94 | None |
| Odonate Therapeutics, Inc. | ODT | 1150.14 | None | 9.42 | -10.22 | None |
| Phibro Animal Health Corp. | PAHC | 1072.15 | 818.00 | 5.41 | 29.06 | 4.49 |
| Athenex, Inc. | ATNX | 1064.70 | 123.00 | 6.53 | -9.89 | -87.86 |
| Akero Therapeutics, Inc. | AKRO | 957.58 | None | 8.00 | -18.87 | None |
| Constellation Pharmaceuticals, Inc. | CNST | 925.12 | None | 4.35 | -9.97 | None |
| G1 Therapeutics, Inc. | GTHX | 818.52 | 1.00 | 3.54 | -6.24 | None |
| Gossamer Bio, Inc. | GOSS | 802.76 | None | 3.26 | -4.04 | None |
| Oric Pharmaceuticals, Inc. | ORIC | 800.80 | None | -8.69 | -26.48 | None |
| Phathom Pharmaceuticals, Inc. | PHAT | 789.50 | None | 4.38 | -2.90 | None |
| Aprea Therapeutics, Inc. | APRE | 769.86 | None | 6.81 | -22.77 | None |
| Quanterix Corp. | QTRX | 752.76 | 60.00 | 6.64 | -17.21 | -71.52 |
| Krystal Biotech, Inc. | KRYS | 731.00 | None | 4.26 | -35.25 | None |
| Applied Therapeutics, Inc. | APLT | 690.14 | 14.00 | 4.46 | -14.00 | -19.41 |
| Provention Bio, Inc. | PRVB | 669.94 | None | 10.60 | -15.13 | None |
| Provention Bio, Inc. | PRVB | 651.88 | None | 10.31 | -14.72 | None |
| Keros Therapeutics, Inc. | KROS | 644.40 | 8.00 | -29.11 | -30.34 | -285.35 |
| Amneal Pharmaceuticals, Inc. | AMRX | 619.24 | 1679.00 | 4.26 | -2.84 | -11.85 |
| Arcturus Therapeutics Holdings, Inc. | ARCT | 605.28 | 19.00 | 56.10 | -21.76 | -151.34 |
| Oyster Point Pharma, Inc. | OYST | 596.40 | None | 5.99 | -10.36 | None |
| Mirum Pharmaceuticals, Inc. | MIRM | 503.75 | None | 3.28 | -7.44 | None |
| SIGA Technologies, Inc. | SIGA | 480.11 | 19.00 | 5.37 | -24.40 | -94.00 |
| Satsuma Pharmaceuticals, Inc. | STSA | 463.25 | None | 4.56 | -12.73 | None |
| Imara, Inc. | IMRA | 461.21 | None | 4.45 | -13.11 | None |
| Biospecifics Technologies Corp. | BSTC | 436.94 | 40.00 | 3.55 | 18.69 | 61.80 |
| DURECT Corp. | DRRX | 416.64 | 28.00 | 32.00 | -17.23 | -82.94 |
| Crinetics Pharmaceuticals, Inc. | CRNX | 414.72 | 1.00 | 5.24 | -7.11 | -447.78 |
| Fulcrum Therapeutics, Inc. | FULC | 410.55 | 1.00 | 6.92 | -5.95 | None |
| 89bio, Inc. | ETNB | 386.40 | None | 4.77 | -5.99 | None |
| Relmada Therapeutics, Inc. | RLMD | 385.02 | 0.00 | 5.74 | -32.17 | -877.66 |
| Ocular Therapeutix, Inc. | OCUL | 383.04 | 6.00 | -46.94 | -4.18 | None |
| Kala Pharmaceuticals, Inc. | KALA | 380.16 | 6.00 | 4.16 | -4.14 | None |
| TCR2 Therapeutics, Inc. | TCRR | 373.20 | None | 2.55 | -37.02 | None |
| Osmotica Pharmaceuticals Plc | OSMT | 361.80 | 232.00 | 2.75 | -1.32 | -115.44 |
| Ovid Therapeutics, Inc. | OVID | 324.90 | None | 7.68 | -4.98 | None |
| Urovant Sciences Ltd. | UROV | 301.80 | None | -5.35 | -2.09 | None |
| Aeglea Biotherapeutics, Inc. | AGLE | 298.98 | 4.00 | 9.44 | -3.73 | -523.27 |
| HOOKIPA Pharma, Inc. | HOOK | 282.88 | 13.00 | 2.56 | -6.25 | -333.02 |
| IDEAYA Biosciences, Inc. | IDYA | 274.60 | None | 4.17 | -6.30 | None |
| AMAG Pharmaceuticals, Inc. | AMAG | 273.70 | 321.00 | 1.05 | -0.74 | -115.05 |
| Lannett Co., Inc. | LCI | 270.56 | 542.00 | 0.92 | -8.90 | -5.77 |
| Verrica Pharmaceuticals, Inc. | VRCA | 257.50 | None | 4.70 | -8.44 | None |
| Spero Therapeutics, Inc. | SPRO | 254.03 | 12.00 | 3.34 | -3.12 | -656.72 |
| Gritstone Oncology, Inc. | GRTS | 236.88 | 4.00 | 2.12 | -2.27 | None |
| KalVista Pharmaceuticals, Inc. | KALV | 233.46 | 12.00 | 2.58 | -7.21 | -263.38 |
| Kaleido Biosciences, Inc. | KLDO | 221.10 | None | 7.84 | -3.02 | None |
| Veru, Inc. | VERU | 211.90 | 39.00 | 7.09 | -21.73 | -25.53 |
| LogicBio Therapeutics, Inc. | LOGC | 191.36 | 1.00 | 5.78 | -4.50 | None |
| Galera Therapeutics, Inc. | GRTX | 180.25 | None | 3.37 | -2.74 | None |
| Liquidia Technologies, Inc. | LQDA | 171.38 | 8.00 | 10.12 | -3.48 | -602.17 |
| Sutro Biopharma, Inc. | STRO | 171.12 | 41.00 | 3.25 | -2.81 | -148.06 |
| Avenue Therapeutics, Inc. | ATXI | 167.52 | 532.00 | 30.79 | -11.51 | 26.69 |
| Protara Therapeutics, Inc. | TARA | 166.14 | None | 2.50 | -10.77 | None |
| Evolus, Inc. | EOLS | 159.60 | 45.00 | 2.86 | -1.57 | -217.51 |
| Cyclerion Therapeutics, Inc. | CYCN | 156.60 | 6.00 | 1.97 | -1.51 | None |
| Tyme Technologies, Inc. | TYME | 148.35 | None | 8.60 | -6.79 | None |
| Evelo Biosciences, Inc. | EVLO | 143.36 | None | 5.27 | -1.64 | None |
| Trevi Therapeutics, Inc. | TRVI | 137.07 | None | 2.91 | -4.67 | None |
| scPharmaceuticals, Inc. | SCPH | 136.04 | 119.00 | 3.48 | -4.34 | -27.05 |
| Harrow Health, Inc. | HROW | 135.72 | 51.00 | 8.70 | -5.49 | -47.54 |
| Lyra Therapeutics, Inc. | LYRA | 134.40 | 1.00 | -1.14 | -8.06 | -491.16 |
| Aquestive Therapeutics, Inc. | AQST | 131.88 | 49.00 | -7.60 | -1.88 | -139.64 |
| PhaseBio Pharmaceuticals, Inc. | PHAS | 127.31 | 2.00 | 2.36 | -2.66 | None |
| Mustang Bio, Inc. | MBIO | 122.40 | None | 2.86 | -2.49 | None |
| TFF Pharmaceuticals, Inc. | TFFP | 121.60 | None | 4.71 | -3.14 | None |
| NeuBase Therapeutics, Inc. | NBSE | 121.24 | None | 50.94 | -2.71 | None |
| Immunic, Inc. | IMUX | 117.40 | None | 3.45 | -53.36 | None |
| Ayala Pharmaceuticals, Inc. | AYLA | 116.40 | 3.00 | -2.74 | -5.64 | -679.19 |
| Eton Pharmaceuticals, Inc. | ETON | 99.36 | 1.00 | 10.82 | -4.97 | None |
| Milestone Pharmaceuticals, Inc. | MIST | 96.75 | None | 0.96 | -1.55 | None |
| Clearside Biomedical, Inc. | CLSD | 79.54 | 6.00 | 10.21 | -4.51 | -293.61 |
| Corvus Pharmaceuticals, Inc. | CRVS | 79.46 | None | 1.27 | -1.68 | None |
| EyePoint Pharmaceuticals, Inc. | EYPT | 78.48 | 26.00 | 5.54 | -1.60 | -196.30 |
| Xeris Pharmaceuticals, Inc. | XERS | 78.12 | 4.00 | 3.87 | -0.60 | None |
| Checkpoint Therapeutics, Inc. | CKPT | 76.80 | 2.00 | 6.62 | -3.31 | -949.53 |
| Baudax Bio, Inc. | BXRX | 72.00 | None | -1.96 | -1.03 | None |
| Navidea Biopharmaceuticals, Inc. | NAVB | 68.34 | 1.00 | -50.25 | -6.18 | -65.13 |
| BiomX, Inc. | PHGE | 65.45 | None | 1.72 | -1.53 | None |
| Genprex, Inc. | GNPX | 59.85 | None | 5.08 | -4.38 | None |
| Assertio Therapeutics, Inc. | ASRT | 59.04 | 192.00 | 1.02 | -0.36 | -83.99 |
| Aridis Pharmaceuticals, Inc. | ARDS | 56.97 | 1.00 | -23.44 | -1.95 | -851.00 |
| Aerpio Pharmaceuticals, Inc. | ARPO | 52.48 | 20.00 | 1.58 | -2.78 | -51.58 |
| Menlo Therapeutics, Inc. | MNLO | 49.01 | 2.00 | 4.12 | -0.52 | -483.51 |
| Eyenovia, Inc. | EYEN | 45.44 | None | 4.58 | -2.22 | None |
| Edesa Biotech, Inc. | EDSA | 44.82 | 0.00 | 6.38 | -0.47 | -395.23 |
| Moleculin Biotech, Inc. | MBRX | 42.69 | None | 3.71 | -4.64 | None |
| Citius Pharmaceuticals, Inc. | CTXR | 36.45 | None | 2.70 | -2.11 | None |
| Akari Therapeutics Plc | AKTX | 36.18 | None | -33.50 | -2.01 | None |
| Oncternal Therapeutics, Inc. | ONCT | 35.75 | 3.00 | 4.58 | -1.42 | -225.89 |
| Mannatech, Inc. | MTEX | 34.80 | 156.00 | 1.47 | 7.84 | 3.45 |
| AgeX Therapeutics, Inc. | AGE | 33.78 | 2.00 | -44.45 | -2.78 | -658.11 |
| Allena Pharmaceuticals, Inc. | ALNA | 33.70 | None | 4.44 | -0.78 | None |
| CNS Pharmaceuticals, Inc. | CNSP | 33.12 | None | 5.75 | -6.09 | None |
| Aileron Therapeutics, Inc. | ALRN | 32.48 | None | 4.46 | -1.22 | None |
| Adamis Pharmaceuticals Corp. | ADMP | 31.90 | 22.00 | 1.22 | -1.08 | -140.33 |
| Acer Therapeutics, Inc. | ACER | 31.20 | 3.00 | 2.28 | -1.20 | -274.69 |
| Annovis Bio, Inc. | ANVS | 26.88 | None | 2.46 | -21.33 | None |
| Millendo Therapeutics, Inc. | MLND | 25.80 | 0.00 | 0.61 | -0.55 | None |
| Hoth Therapeutics, Inc. | HOTH | 25.00 | None | 6.94 | -2.78 | None |
| Spring Bank Pharmaceuticals, Inc. | SBPH | 23.20 | 0.00 | 0.88 | -0.89 | None |
| Akorn, Inc. | AKRX | 22.68 | 721.00 | -1.20 | -0.06 | -55.64 |
| Daré Bioscience, Inc. | DARE | 18.81 | 1.00 | 8.25 | -1.13 | None |
| ProPhase Labs, Inc. | PRPH | 16.80 | 9.00 | 1.52 | -5.60 | -31.15 |
| Teligent, Inc. | TLGT | 14.40 | 60.00 | -0.49 | -0.36 | -71.80 |
| Teligent, Inc. | TLGT | 14.40 | 60.00 | -0.49 | -0.36 | -71.80 |
| Novan, Inc. | NOVN | 14.21 | 5.00 | -3.27 | -0.45 | -602.34 |
| Adial Pharmaceuticals, Inc. | ADIL | 13.80 | None | 3.37 | -1.82 | None |
| Titan Pharmaceuticals, Inc. | TTNP | 12.00 | 4.00 | 5.00 | -0.67 | -437.91 |
| PDS Biotechnology Corp. | PDSB | 11.69 | None | 1.29 | -0.46 | None |
| Novus Therapeutics, Inc. | NVUS | 7.39 | None | 0.63 | -0.35 | None |
| Brickell Biotech, Inc. | BBI | 5.05 | 5.00 | 1.66 | -0.07 | -432.19 |
| BioStar Pharmaceuticals, Inc. | BSPM | 0.21 | 0.00 | 0.01 | 0.10 | 294.01 |
Latest insider transactions
| Date | Role | Name | Transaction | Quantity | Quantity Owned After |
|---|
Adamis Pharmaceuticals Provides Update on SYMJEPI Products
SAN DIEGO, July 01, Jul 01, 2020 (GLOBE NEWSWIRE via COMTEX) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that, on July 1, 2020, USWM, LLC ("USWM" or "US WorldMeds") began ...
Adamis Pharmaceuticals Corp.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
ADMP Adamis Pharmaceuticals Corporation Common Stock
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...
BRIEF-Adamis Pharmaceuticals Says FDA Indicated Co's Resubmitted NDA For Zimhi As Class 2 Response To Agency's CRL
ADAMIS PHARMACEUTICALS - FDA HAS INDICATED THAT IT CONSIDERS CO’S RESUBMITTED NDA FOR FOR ZIMHI AS A COMPLETE, CLASS 2 RESPONSE TO FDA’S CRL * ADAMIS PHARMACEUTICALS - FDA HAS PROVIDED A USER FEE GOAL ...
Adamis Pharmaceuticals Provides Update on SYMJEPI Products
SAN DIEGO, July 01, Jul 01, 2020 (GLOBE NEWSWIRE via COMTEX) -- SAN DIEGO, July 01, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that, on July 1 ...
Adamis Pharmaceuticals Provides Update on SYMJEPI Products
SAN DIEGO, July 01, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that, on July 1, 2020, USWM, LLC (“USWM” or “US ...
Adamis Pharmaceuticals Provides Update on SYMJEPI Products
Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net SAN DIEGO, July 01, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that ...